$AZN SEC Filings

Filed On	Filing
27 Oct 2026	6-K
22 Oct 2026	ULTOMIRIS APPROVED IN US IN IGAN
08 Oct 2026	Form 4: Sharma Mani, See remarks Received 2 shares as a grant or award ($320)
05 Oct 2026	ASTRAZENECA COMPLETES EQUITY INVESTMENT IN SUMMIT
02 Oct 2026	AZ & DS COLLABORATION WITH SUMMIT FOR DATROWAY
01 Oct 2026	ADMISSION OF FURTHER SECURITIES TO TRADING
01 Oct 2026	TOTAL VOTING RIGHTS
29 Sep 2026	ASTRAZENECA ANNOUNCES EQUITY INVESTMENT IN SUMMIT
23 Sep 2026	TRIXEO APPROVED IN EU FOR ASTHMA
21 Sep 2026	KLYGEFA RECOMMENDED FOR EU APPROVAL BY CHMP
21 Sep 2026	ENHERTU RECOMMENDED FOR APPROVAL IN EU IN EARLY BC
18 Sep 2026	DIRECTOR/PDMR SHAREHOLDING
15 Sep 2026	DIRECTOR/PDMR SHAREHOLDING
15 Sep 2026	DIRECTOR/PDMR SHAREHOLDING
14 Sep 2026	UPDATE ON SERENA-4 PHASE III TRIAL
11 Sep 2026	Form 4: Sharma Mani, See Remarks Bought 20.233 shares ($3.25K) · Received 1 shares as a grant or award ($163)
08 Sep 2026	IMFINZI+IMDELLTRA IMPROVED OS IN SMALL CELL LUNG
08 Sep 2026	ETCAMAH APPROVED IN THE US FOR HR+ BREAST CANCER
01 Sep 2026	ADMISSION OF FURTHER SECURITIES TO TRADING
01 Sep 2026	TOTAL VOTING RIGHTS

Comments